Criteria for the Diagnosis of Lupus Anticoagulants: An Update: On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH

Antiphospholipid Syndrome Review

Eby, C. (2009) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2009.06.001 · Cited by 14

Thrombin activatable fibrinolysis inhibitor and clot lysis time in women with recurrent miscarriage associated with the antiphospholipid syndrome

Martínez‐Zamora, M. Á., Creus, M. T., Tàssies, D., et al. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.02.032 · Cited by 14

The clinical significance of anti-prothrombin antibodies for risk assessment of thromboembolism in patients with lupus anticoagulant

Sailer, T., Vormittag, R., Zoghlami, C., et al. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2007.01.001 · Cited by 14

The epidemiology of the antiphospholipid syndrome: Who is at risk?

Finazzi, G. (2001) · Current Rheumatology Reports · doi:10.1007/s11926-001-0030-5 · Cited by 14

Phospholipid Autoantibodies and the Antiphospholipid Antibody Syndrome: Diagnostic Accuracy of 23 Methods Studied by Variation in ROC Curves with Number of Clinical Manifestations

Wasmuth, J., Oliver‐Miñarro, D., Homrighausen, A., Leifeld, L., Rockstroh, J. K., Sauerbruch, T., & Spengler, U. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.7.1004 · Cited by 14

Diagnostic analysis of lupus anticoagulant using clot waveform analysis in activated partial thromboplastin time prolonged cases: A retrospective analysis

Kanouchi, K., Narimatsu, H., Shirata, T., & Morikane, K. (2021) · Health Science Reports · doi:10.1002/hsr2.258 · Cited by 13

Antiphospholipid Antibodies Associated with Native Arteriovenous Fistula Complications in Hemodialysis Patients: A Comprehensive Review of the Literature

Taghavi, M., Jabrane, A., Jacobs, L., Mesquita, M. D. C. F., Demulder, A., & Nortier, J. (2024) · Antibodies · doi:10.3390/antib13010001 · Cited by 14

Antiphospholipid antibodies and hypertension

Rollino, C., Boero, R., Elia, F., et al. (2004) · Lupus · doi:10.1191/0961203304lu1082oa · Cited by 13

The IgM isotype of anti-annexin A5 antibodies and multiple positivity of conventional antiphospholipid antibodies: increasing the number of clinical manifestations of primary antiphospholipid syndrome

Bećarević, M. B., Stojanovich, L., Ignjatović, S., & Dopsaj, V. (2016) · Clinical Rheumatology · doi:10.1007/s10067-016-3230-0 · Cited by 13

Functional Lupus Anticoagulant Testing in a Large Retrospective Cohort of Thrombosis Patients with Direct Oral Anticoagulants

Reda, S., Brügelmann, A., Müller, J., Oldenburg, J., Pötzsch, B., & Rühl, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-69199-1 · Cited by 14

Clinical audit of antiphospholipid antibody testing in tertiary practice: towards improved relevance in thrombophilia investigations

Favaloro, E. J., Reben, R., Mohammed, S., & Koutts, J. (2010) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2010.02329.x · Cited by 14

Evaluation of a new commercial dilute prothrombin time in the diagnosis of Lupus Anticoagulants

Devreese, K. M. J. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2008.04.005 · Cited by 14

The involvement of CD36 in monocyte activation by antiphospholipid antibodies

Kato, M., Atsumi, T., Oku, K., Amengual, O., Nakagawa, H., Fujieda, Y., Otomo, K., Horita, T., Yasuda, S., & Koike, T. (2013) · Lupus · doi:10.1177/0961203313490242 · Cited by 13

Bioassay-Guided Fractionation of Melastoma malabathricum Linn. Leaf Solid Phase Extraction Fraction and Its Anticoagulant Activity

Khoo, L. T., Abdullah, J. O., Abas, F., et al. (2015) · Molecules · doi:10.3390/molecules20033697 · Cited by 13

Association of Nail Dystrophy With Accrued Damage and Capillaroscopic Abnormalities in Systemic Lupus Erythematosus

la Higuera, V. M. D., Amezcua-Guerra, L. M., Montoya, H., et al. (2015) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000000336 · Cited by 13

Prediction of ischemic stroke in young Indians

Chatterjee, T., Gupta, N., Choudhry, V. P., et al. (2013) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e32835bfe21 · Cited by 13

Lipoprotein (a) and apolipoprotein (a) in primary antiphospholipid syndrome

Bećarević, M. B., Singh, S., & Majkić‐Singh, N. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.11.018 · Cited by 13

Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation

Ieko, M., Yoshida, M., Naito, S., et al. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0590-0 · Cited by 13

A functional coagulation test to identify anti-β2-glycoprotein I dependent lupus anticoagulants

Devreese, K. M. J. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2006.06.003 · Cited by 13

Avoiding errors in the laboratory evaluation of potent lupus anticoagulants

Penmetsa, G. K., Rodgers, G. M., & Smock, K. J. (2010) · American Journal of Hematology · doi:10.1002/ajh.21666 · Cited by 14

HLA associations of anti-beta2 glycoprotein I response in a Greek cohort with antiphospholipid syndrome and meta-analysis of four ethnic groups

Ioannidis, J. P. A., Tektonidou, M. G., Vlachoyiannopoulos, P. G., Stavropoulos‐Giokas, C., Spyropoulou‐Vlachou, M., Reveille, J. D., Arnett, F. C., & Moutsopoulos, H. Μ. (1999) · Human Immunology · doi:10.1016/s0198-8859(99)00122-6 · Cited by 13

Antiphospholipid Antibodies Syndrome Associated with Hyperhomocysteinemia Related to MTHFR Gene C677T and A1298C Heterozygous Mutations in a Young Man with Idiopathic Hypoparathyroidism (DiGeorge Syndrome)

Nucera, C., Vaccaro, M., Moleti, M., Priolo, C., Tortorella, G., Angioni, A., Ientile, R., Violi, M. A., Loda, M. F., Trimarchi, F., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2782 · Cited by 13

Assessment of thrombotic risk factors predisposing to thromboembolic complications in prosthetic orthopedic surgery

Szűcs, G., Ajzner, É., Muszbek, L., et al. (2009) · Journal of Orthopaedic Science · doi:10.1007/s00776-009-1368-1 · Cited by 13

Is recurrent venous thromboembolism more frequent in homozygous patients for the factor V Leiden mutation than in heterozygous patients?

The Procare Group (2003) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200309000-00002 · Cited by 13

Lupus Anticoagulant Testing with Optical End Point Automation

Luddington, R. J., Scales, C., & Baglin, T. P. (1999) · Thrombosis Research · doi:10.1016/s0049-3848(99)00096-1 · Cited by 13

Late spontaneous remissions in severe adult autoimmune thrombocytopenia

Simanek, R., Panzer, S., Lechner, K., et al. (2007) · Annals of Hematology · doi:10.1007/s00277-007-0309-3 · Cited by 13

Deep venous thrombosis and pulmonary embolism after knee arthroscopy in athletes carrying the thrombophilic factor lupus anticoagulant

Pola, E., Flex, A., Papaleo, P., et al. (2005) · Arthroscopy The Journal of Arthroscopic and Related Surgery · doi:10.1016/j.arthro.2004.09.028 · Cited by 13

Pathogenetic Potential of Antiphospholipid Antibodies

Vlachoyiannopoulos, P. G., & Samarkos, M. (2006) · Future Cardiology · doi:10.2217/14796678.2.3.303 · Cited by 13

Non-Criteria Obstetric Antiphospholipid Syndrome: How Different Is from Sidney Criteria? A Single-Center Study

Martínez-Taboada, V. M., Blanco-Olavarri, P., Barrio-Longarela, S. D., Riancho‐Zarrabeitia, L., Merino, A., Comins‐Boo, A., López‐Hoyos, M., & Hernández, J. L. (2022) · Biomedicines · doi:10.3390/biomedicines10112938 · Cited by 12

Evaluating laboratory approaches to the identification of lupus anticoagulants: A diagnostic challenge from the RCPA Haematology QAP

Bonar, R. A., Favaloro, E. J., Zebeljan, D., Rosenfeld, D., Kershaw, G., Mohammed, S., MARSDEN, K. A., & Hertzberg, M. (2011) · Pathology · doi:10.1097/pat.0b013e32834d7b83 · Cited by 12

Performance evaluation of Revohem™ FVIII chromogenic and Revohem™ FIX chromogenic in the CS‐5100 autoanalyser

Suzuki, A., Suzuki, N., Kanematsu, T., et al. (2019) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13083 · Cited by 12

Differences in the INR evaluation of two different thromboplastins in patients with positivity to lupus anticoagulant in ongoing oral anticoagulation

Micco, P. D. (2010) · Journal of Blood Medicine · doi:10.2147/jbm.s8938 · Cited by 12

Antiphospholipid Antibodies: Laboratory and Pathogenetic Aspects

Vlachoyiannopoulos, P. G., Samarkos, M., Sikara, M. P., & Tsiligros, P. (2007) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360601079549 · Cited by 12

The detection of anti-β2-glycoprotein I antibodies is associated with increased risk of pregnancy loss in women with threatened abortion in the first trimester

Mezzesimi, A., Florio, P., dos Reis, F. M., et al. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2006.08.018 · Cited by 12

Study of clinical utility of antibodies to phosphatidylserine/prothrombin complex in Asian-Indian patients with suspected APS

Ganapati, A., Goel, R., Kabeerdoss, J., Gowri, M. S., Mathew, J., & Danda, D. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-4301-1 · Cited by 12

Efficacy and safety of nadroparin and unfractionated heparin for the treatment of venous thromboembolism during pregnancy and puerperium

Mitic, G. P., Kovac, M. K., Považan, L., Djordjevic, V. J., Ilić, V. L., Salatić, I., Lazic, R., Antonijevic, N. M., & Novakov-Mikić, A. S. (2010) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh10s1018m · Cited by 12

Acquired activated protein C resistance, high tissue factor expression, and hyper‐homocysteinemia in systemic lupus erythematosus

Oh, D., Kim, S.-Y., Kang, M. S., et al. (2003) · American Journal of Hematology · doi:10.1002/ajh.10279 · Cited by 12

Is the determination of anti‐beta2 glycoprotein I antibodies useful in patients with venous thromboembolism without the antiphospholipid syndrome?

Hsieh, K., Knöbl, P., Rintelen, C., Kyrle, P. A., Quehenberger, P., Bialonczyk, C., Partsch, H., Lechner, K., & Pabinger, I. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04595.x · Cited by 12

A Simplified Algorithm for the Laboratory Detection of Lupus Anticoagulants

Zhang, L., Whitis, J. G., Embry, M. B., & Hollensead, S. C. (2005) · American Journal of Clinical Pathology · doi:10.1309/6hye47508gwttc4e · Cited by 12

Recent advances in the diagnosis of antiphospholipid syndrome

Chi, H. (2002) · International Journal of Hematology · doi:10.1007/bf03165086 · Cited by 12

Primary Recurrent Miscarriages: Anti–β2-Glycoprotein I IgG Antibodies Induce an Acquired Activated Protein C Resistance That Can Be Detected by the Modified Activated Protein C Resistance Test

Mercier, É., Quéré, I., Marès, P., et al. (1998) · Blood · doi:10.1182/blood.v92.8.2993 · Cited by 12

Proliferative Vasculopathy Associated With Antiphospholipid Antibodies in Patients With Neurological Symptoms

Yeo, J., Hwang, I., Sohn, C., Lee, E. E., Lee, S., Lee, E. B., & Park, J. K. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.913203 · Cited by 11

Diagnosis and management of antiphospholipid syndrome in pregnancy

Myers, B., & Pavord, S. R. (2011) · The Obstetrician & Gynaecologist · doi:10.1576/toag.13.1.15.27636 · Cited by 11

Performance Characteristics of Commercial Immunoassays for the Detection of IgG and IgM Antibodies to β2Glycoprotein I and an Initial Assessment of Newly Developed Reference Materials for Assay Calibration

Willis, R., Pierangeli, S. S., Jaskowski, T. D., Malmberg, E. M., Guerra, M. M., Salmon, J. E., Petri, M., Branch, D. W., & Tebo, A. E. (2016) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqw065 · Cited by 11

Interpretation of autoantibodies in rheumatological diseases

Méndez‐Rayo, T., Ochoa-Zárate, L., Posso‐Osorio, I., Ortíz, E., Naranjo-Escobar, J., & Tobón, G. J. (2018) · Revista Colombiana de Reumatología (English Edition) · doi:10.1016/j.rcreue.2019.01.001 · Cited by 11

Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation

Miesbach, W., Scharrer, I., & Asherson, R. A. (2004) · Clinical Rheumatology · doi:10.1007/s10067-004-0864-0 · Cited by 11

Direct Thrombin Inhibitors and Factor Xa Inhibitors Can Influence the Diluted Prothrombin Time Used as the Initial Screen for Lupus Anticoagulant

Olah, Z., Szarvas, M., Bereczky, Z., Kerenyi, A., Kappelmayer, J., & Boda, Z. (2013) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2012-0236-oa · Cited by 11

High grade heart block in association with SLE

Edwards, C., Mootoo, R., & Bhanji, A. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2002.005322 · Cited by 10

Association between academic performance and cognitive dysfunction in patients with juvenile systemic lupus erythematosus

Frittoli, R. B., Peliçari, K. D. O., Bellini, B. S., et al. (2016) · Revista Brasileira de Reumatologia (English Edition) · doi:10.1016/j.rbre.2016.03.005 · Cited by 11

Lupus Anticoagulant Testing

Moffat, K. A., Raby, A., & Crowther, M. A. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-339-8_7 · Cited by 11

Cognitive dysfunction and serum levels of brain-derived neurotrophic factor (BDNF) in primary anti-phospholipid syndrome (PAPS)

Rosa, R. F., Lopes, M. R. U., Gândara, A. P. R., Vendramini, M. B. G., Campanholo, K. R., Dutra, L. A., & ANDRADE, D. C. O. D. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa252 · Cited by 13

Antiphospholipid syndrome: the need for new international classification criteria

Hasbani, G. E., Taher, A. T., Sciascia, S., & Uthman, I. W. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1900733 · Cited by 11

Incidence and Clinical Importance of Lupus Anticoagulant in Children With Recurrent Upper Respiratory Tract Infection

Peker, E., Kavaklı, K., Balkan, C., et al. (2009) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029609351292 · Cited by 11

Clinical and serological follow-up of 71 patients with anti-mitochondrial type 5 antibodies

Andrejević, S., Nikolic, B. B., Šefik-Bukilica, M., & Petrovic, R. (2007) · Lupus · doi:10.1177/0961203307081913 · Cited by 11

Antiphospholipid antibodies in children with systemic lupus erythematosus: a prospective study in northern India

Ahluwalia, J., Singh, S., & Garewal, G. (2004) · Rheumatology International · doi:10.1007/s00296-004-0501-x · Cited by 11

Antiphospholipid antibodies in critical illness

Dentali, F., & Crowther, M. A. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c9e363 · Cited by 11

Antiphospholipid Antibodies in Dogs with Immune Mediated Hemolytic Anemia, Spontaneous Thrombosis, and Hyperadrenocorticism

Miller, A. G., DOW, S. W., Long, L. J., & Olver, C. S. (2012) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2012.00922.x · Cited by 11

To Mix with Pooled Normal Plasma or Not to Mix: A Comparative Study of 2 Approaches for Assessing Lupus Anticoagulant Inhibitory Activity in the Dilute Russell Viper Venom Method

Aboud, M., RODDIE, C., Wård, C., & Coyle, L. A. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.078683 · Cited by 11

Quantifying subclinical central nervous lesions in primary antiphospholipid syndrome: The role of magnetization transfer imaging

ANDRADE, D. C. O. D., Borba, E. F., Bonfá, E., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21308 · Cited by 11

Hereditary and Acquired Thrombophilia in Splanchnic Vein Thrombosis

Mutreja, D., Kotru, M., Sazawal, S., et al. (2013) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029613511520 · Cited by 11

The Relationship between P-Selectin Polymorphisms and Thrombosis in Antiphospholipid Syndrome: A Pilot Case-Control Study

Alpay, N., Hançer, V. S., Erer, B., et al. (2014) · Turkish Journal of Hematology · doi:10.4274/tjh.2013.0091 · Cited by 11

Antiphospholipid Antibodies:

Riley, R. S., Friedline, J. A., & Rogers, J. S. (1997) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30203-8 · Cited by 10

Single Center Review of Clinicopathological Characterization in 77 Patients with Positive Lupus Anticoagulant Antibodies

Owaidah, T. M., Qurashi, F.-H. M., Nounou, R., Zahrani, H. A., Mussa, A. A., Tbakhi, A., Daama, S. A. A., Elkum, N. B., & Roberts, G. T. (2003) · Hematology · doi:10.1080/10245330310001594216 · Cited by 11

Antiphospholipid antibodies in 57 children and adolescents with systemic lupus erythematosus

Campos, L. M. A., Kiss, M. H. B., D’Amico, É. A., et al. (2003) · Revista do Hospital das Clínicas · doi:10.1590/s0041-87812003000300005 · Cited by 11

Antiphospholipid antibodies and platelet activation as risk factors for thrombosis in thrombocythaemia

Bidot, C., Jy, W., Horstman, L. L., et al. (2005) · Hematology · doi:10.1080/10245330500226860 · Cited by 11

Laboratory detection of antiphospholipid antibodies

Kandiah, D. A., & Krilis, S. (1996) · Lupus · doi:10.1177/096120339600500215 · Cited by 11

Activation dependent apoptosis of peripheral blood mononuclear cells from patients with rheumatoid arthritis treated with methotrexate

Świerkot, J., Miedzybrodzki, R., Szymaniec, S., & Szechinski, J. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.015370 · Cited by 11

Thrombophilia: What's a Practitioner to Do?

Macik, B. G., Rand, J. H., & Konkle, B. A. (2001) · Hematology · doi:10.1182/asheducation-2001.1.322 · Cited by 11

Thrombophilia in the Infant and Child

Manco‐Johnson, M. J., & Nuss, R. (2001) · Advances in Pediatrics · doi:10.1016/s0065-3101(23)00083-x · Cited by 11

ANTIBODIES TO THROMBOPLASTIN IN SYSTEMIC LUPUS ERYTHEMATOSUS: ISOTYPE DISTRIBUTION AND CLINICAL SIGNIFICANCE IN A SERIES OF 92 PATIENTS

Font, J., López‐Soto, A., Cervera, R., Casals, F. J., Reverter, J. C., Muñoz, F. J., Miret, C., Bové, A., Ordinas, A., & Ingelmo, M. (1997) · Thrombosis Research · doi:10.1016/s0049-3848(97)00043-1 · Cited by 11

Antiphospholipid antibodies and thrombosis

Musiał, J. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.10.029 · Cited by 10

Factor V inhibitor: case report

Leus, B., Devreese, K. M. J., den Bossche, J. V., et al. (2006) · Blood Coagulation & Fibrinolysis · doi:10.1097/01.mbc.0000245291.57021.0f · Cited by 10

Life-threatening cardiac manifestations of primary antiphospholipid syndrome

Grzybczak, R., Undas, A., Rostoff, P., Gackowski, A., Czubek, U., Stopyra, K., & Piwowarska, W. (2010) · Heart and Vessels · doi:10.1007/s00380-009-1193-7 · Cited by 10

Mycosis fungoides masquerading as cutaneous lupus erythematosus and associated with antiphospholipid syndrome

Veysey, E. C., & Wilkinson, J. D. (2007) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2007.02546.x · Cited by 10

Polymorphism of the plasminogen activator inhibitor type 1 gene, plasminogen level and thromboses in patients with the antiphospholipid syndrome

Айсина, Р. Б., Mukhametova, L. I., Ostryakova, E. V., et al. (2013) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750813010010 · Cited by 10

Associação entre desempenho acadêmico e disfunção cognitiva em pacientes com lúpus eritematoso sistêmico juvenil

Frittoli, R. B., Peliçari, K. D. O., Bellini, B. S., et al. (2016) · Revista Brasileira de Reumatologia · doi:10.1016/j.rbr.2016.01.002 · Cited by 10

IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients

Sciascia, S., Cecchi, I., Radin, M., Rubini, E., Suárez, A., Roccatello, D., & Rodríguez‐Carrio, J. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00211 · Cited by 10

Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies

Radin, M., Cecchi, I., Foddai, S. G., Rubini, E., Barinotti, A., Ramirez, C., Seaman, A., Roccatello, D., Mähler, M., & Sciascia, S. (2020) · Biomedicines · doi:10.3390/biomedicines8120622 · Cited by 9

Anticuerpos antifosfolípido y síndrome antifosfolípido: actitudes diagnósticas y terapéuticas

García, C. G. (2007) · Actas Dermo-Sifiliográficas · doi:10.1016/s0001-7310(07)70004-2 · Cited by 10

Phlegmasia cerulea dolens as a complication of deep vein thrombosis in a man with primary antiphospholipid syndrome

Padjas, A., Brzezińska-Kolarz, B., Undas, A., et al. (2005) · Blood Coagulation & Fibrinolysis · doi:10.1097/01.mbc.0000191910.24780.81 · Cited by 10

Prevalence of nonspecific cutaneous vascular lesions and association with antiphospholipid antibodies in patients with systemic lupus erythematosus

Hawro, T., Maurer, M., Sysa‐Jędrzejowska, A., et al. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11077.x · Cited by 10

The prevalence of lupus anticoagulant in normal pregnancy and in women with recurrent fetal loss—recommendations for laboratory testing for lupus anticoagulant

Al‐Meshari, A. A., Gader, A. G. M. A., Al-Jabbari, A. W., Al-Momen, A. K. M., Rab, M. O. G. E., Babay, Z. A., & Mahmoud, N. (2004) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2004.429 · Cited by 10

Isolated cranial nerve syndromes without proximal carotid involvement in aortoarteritis

Shroff, G. R., Karnad, D. R., Limaye, U. S., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.010389 · Cited by 10

Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies

Devreese, K. M. J. (2024) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0044-1791699 · Cited by 13

Management of patients with antiphospholipid antibodies: what to do in laboratory scenarios that do not fit the guidelines

da Rosa, G. P., Rodríguez‐Pintó, I., Cervera, R., & Espinosa, G. (2021) · Expert Review of Hematology · doi:10.1080/17474086.2021.1923474 · Cited by 9

Microstructural Changes in the Corpus Callosum in Systemic Lupus Erythematous

Júlio, P. R., Caldeira, T., Pinheiro, G. R., Cappello, C. H., Fritoli, R. B., Marini, R., Cendes, F., Fernandes, P. T., Costallat, L. T. L., Rittner, L., et al. (2023) · Cells · doi:10.3390/cells12030355 · Cited by 10

Increased frequency of class I and II anti‐human leukocyte antigen antibodies in systemic lupus erythematosus and scleroderma and associated factors: a comparative study

Tozkır, H., Pamuk, Ö. N., Duymaz, J., et al. (2014) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12484 · Cited by 9

Lupus anticoagulant

Poz, A., Pradella, P., Azzarini, G., Santarossa, L., Bardin, C., Zardo, L., & Giacomello, R. (2015) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000414 · Cited by 9

Panniculitis in childhood-onset systemic lupus erythematosus: a multicentric cohort study

Verdier, M., Anuardo, P., Gormezano, N. W. S., et al. (2019) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-019-0049-9 · Cited by 9

ORIGINAL ARTICLE: Thrombin Activatable Fibrinolysis Inhibitor and Clot Lysis Time in Pregnant Patients with Antiphospholipid Syndrome: Relationship with Pregnancy Outcome and Thrombosis

Martínez‐Zamora, M. Á., Tàssies, D., Carmona, F., et al. (2009) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2009.00751.x · Cited by 9

The Activated Seven Lupus Anticoagulant Assay Detects Clinically Significant Antibodies

Moore, G. W., Rangarajan, S., & Savidge, G. F. (2007) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029607305099 · Cited by 9

The antiphospholipid antibody syndrome

Nimmo, M., & Carter, C. J. (2003) · Clinical and Applied Immunology Reviews · doi:10.1016/s1529-1049(03)00047-3 · Cited by 8

Multiple presence of prothrombotic risk factors in Croatian children with arterial ischemic stroke and transient ischemic attack

Krleža, J. L., Đuranović, V., Bronić, A., et al. (2013) · Croatian Medical Journal · doi:10.3325/cmj.2013.54.346 · Cited by 9

More on: criteria to define the antiphospholipid syndrome

Tripodi, A. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02960.x · Cited by 9

Morbidity of lupus anticoagulants in children: a single institution experience

Casais, P., Meschengieser, S. S., Gennari, L., et al. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.06.006 · Cited by 9

Low C 3 levels is associated with neutropenia in a proportion of patients with myelodysplastic syndrome: retrospective analysis

Kim, K., Kwok, S., Park, Y., Kim, W., & Cho, C. (2012) · International Journal of Rheumatic Diseases · doi:10.1111/j.1756-185x.2012.01704.x · Cited by 9

Management of lepirudin therapy for a patient with antiphospholipid antibody syndrome using the whole blood ecarin clot time and activated partial thromboplastin time

Perry, S. L., O’Shea, S. I., & Ortel, T. L. (2003) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200309000-00014 · Cited by 9

Improved confirmation of weak lupus anticoagulants by employing sensitive and insensitive reagents to the lupus anticoagulant

Ames, P. R. J., Iannaccone, L., Iasio, R. D., et al. (2001) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200110000-00009 · Cited by 9

The FXIIIVal34Leu, common and risk factors of venous thrombosis in early middle‐age Costa Rican patients

Salazar‐Sánchez, L., Leon, M. P., Cartín, M., et al. (2006) · Cell Biochemistry and Function · doi:10.1002/cbf.1389 · Cited by 9

Syndrome des antiphospholipides

HACHULLA, E., Darnige, L., & Arvieux, J. (2007) · Encyclopédie médico-chirurgicale. Hématologie · doi:10.1016/s1155-1984(07)46644-4 · Cited by 9

Assays for Measuring Rivaroxaban: Their Suitability and Limitations

Lindhoff‐Last, E., Samama, M. M., Ortel, T. L., Weitz, J. I., & Spiro, T. E. (2010) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181f2f264 · Cited by 157

Rivaroxaban for Thromboprophylaxis in Patients with Antiphospholipid Syndrome

Park, J. H., Song, J. S., & Choi, S. T. (2017) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2017.24.2.108 · Cited by 1

Developing Deep Venous Thrombosis while on Rivaroxaban: A Review of Rivaroxaban

Al-Khafaji, R. A. (2020) · Clinical Case Reports · doi:10.37421/jccr.2020.10.1365 · Cited by 1

Can an anti-Xa assay for low-molecular-weight heparin be used to assess the presence of rivaroxaban?

Yates, S. G., Smith, S., Tharpe, W., Shen, Y.-M., & Sarode, R. (2016) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2016.06.005 · Cited by 18

Antiphospholipid and Thrombosis Syndromes

Bick, R. L., & Baker, W. (1994) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1001885 · Cited by 57